32 related articles for article (PubMed ID: 9708526)
1. In females, salivary secretion was significantly lower in patients with severe reflux esophagitis than in healthy controls.
Hoshino S; Momma E; Koeda M; Hoshikawa Y; Tanabe T; Kawami N; Kitasako Y; Iwakiri K
Esophagus; 2024 Jul; 21(3):383-389. PubMed ID: 38536601
[TBL] [Abstract][Full Text] [Related]
2. Saliva Secretion Is Significantly Lower in Female Patients with Mild Reflux Esophagitis than in Female Healthy Controls.
Momma E; Koeda M; Hoshikawa Y; Tanabe T; Hoshino S; Kitasako Y; Kawami N; Iwakiri K
Digestion; 2023; 104(4):299-305. PubMed ID: 36750039
[TBL] [Abstract][Full Text] [Related]
3. The Role of Salivary Gland Scintigraphy in the Evaluation of Salivary Gland Dysfunction in Uncontrolled Type II Diabetic Patients.
Senthilkumar B; Sathasivasubramanian S
World J Nucl Med; 2013 Sep; 12(3):94-100. PubMed ID: 25214812
[TBL] [Abstract][Full Text] [Related]
4. Systematic review: cardiovascular safety profile of 5-HT(4) agonists developed for gastrointestinal disorders.
Tack J; Camilleri M; Chang L; Chey WD; Galligan JJ; Lacy BE; Müller-Lissner S; Quigley EM; Schuurkes J; De Maeyer JH; Stanghellini V
Aliment Pharmacol Ther; 2012 Apr; 35(7):745-67. PubMed ID: 22356640
[TBL] [Abstract][Full Text] [Related]
5. Evidence for decreased salivary function in patients with reflux esophagitis.
Kao CH; Ho YJ; ChangLai SP; Liao KK
Digestion; 1999; 60(3):191-5. PubMed ID: 10343131
[TBL] [Abstract][Full Text] [Related]
6. Cisapride versus ranitidine in the treatment of reflux esophagitis.
Janisch HD; Hüttemann W; Bouzo MH
Hepatogastroenterology; 1988 Jun; 35(3):125-7. PubMed ID: 3042576
[TBL] [Abstract][Full Text] [Related]
7. [Results of the treatment of gastroesophageal reflux and peptic esophagitis using cisapride].
Carrasco Gandía S; Lama Moré R; Prieto Bozano G; Polanco Allue I
An Esp Pediatr; 1990 Jun; 32(6):485-8. PubMed ID: 2221622
[TBL] [Abstract][Full Text] [Related]
8. Effects of cisapride on salivary production in normal subjects.
Patel R; Launspach J; Soffer E
Dig Dis Sci; 1996 Mar; 41(3):480-4. PubMed ID: 8617119
[TBL] [Abstract][Full Text] [Related]
9. The effect of cisapride in patients with reflux esophagitis: an ambulatory esophageal manometry/pH-metry study.
Paterson WG; Wang H; Beck IT
Am J Gastroenterol; 1997 Feb; 92(2):226-30. PubMed ID: 9040196
[TBL] [Abstract][Full Text] [Related]
10. Salivary function in patients with reflux esophagitis: effect of cisapride.
Chen SD; Kao CH; Chang CS; Chen GH
J Nucl Med; 1998 Aug; 39(8):1449-52. PubMed ID: 9708526
[TBL] [Abstract][Full Text] [Related]
11. [Reflux esophagitis: therapeutic indications].
Cloarec D; Bruley des Varannes S; Galmiche JP
Rev Prat; 1988 Feb; 38(4):237-48. PubMed ID: 2895495
[No Abstract] [Full Text] [Related]
12. Prokinetic therapy in gastroesophageal reflux disease.
Champion MC
Can J Gastroenterol; 1997 Sep; 11 Suppl B():55B-65B. PubMed ID: 9347180
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
